AI Is Reshaping Medicine — but Trust Has Not Kept Up
In hospitals and clinics across the United States, artificial intelligence is becoming part of the daily fabric of medical care — analyzing radiology images, drafting clinical notes, predicting sepsis risk, flagging medication errors, and helping physicians navigate thousands of pages of current evidence in seconds.
By nearly every objective measure, these tools are working. They are reducing burnout, improving diagnostic accuracy, and freeing clinicians to spend more time with patients. But a massive new global survey released this week reveals a complication that technology alone cannot solve: the people using these tools — and the people being treated by them — do not yet fully trust them.
The 2026 Future Health Index, Philips' tenth annual survey of global healthcare trends, surveyed clinicians across multiple countries and paints a nuanced, sometimes troubling portrait of AI adoption in medicine: extraordinary promise, real measurable results — and a deepening trust deficit that threatens to undermine both.
For American healthcare consumers, the findings are directly relevant. AI is already in the room during your next doctor's visit, even if no one told you it was there.
What the Data Shows
Nearly two-thirds (65%) of clinicians have increased their use of AI tools provided at work, with measurable benefits. The survey found that 82% of clinicians see or expect their roles to move to higher-value activities, and 71% say AI will help them to work at the top of their capabilities.
On the patient side, 52% of patients say they use AI to research health conditions or diagnoses, and 54% say they use AI tools to look up potential side effects or drug interactions. That is not a small minority — it is a majority of patients walking into appointments with AI-assisted impressions of their own health before a physician has examined them.
The clinical implications of this shift are significant. Three-quarters (74%) of clinicians report patients arriving at consultations AI-informed, and 63% of them regard informed patients as integral to future care.
Yet the same report documents that the trust gap is real and consequential. The Wolters Kluwer 2026 Future Ready Healthcare survey found that while AI adoption is rising rapidly, trust among both clinicians and patients has not kept pace — creating a system where AI tools are being used more broadly than the confidence in them would warrant.
The concern most often cited by clinicians is AI hallucination: the well-documented tendency of large language model-based AI systems to generate confident-sounding but factually incorrect medical information. In clinical decision support, a confident wrong answer can be more dangerous than acknowledged uncertainty.
What AI Is Actually Doing Well in U.S. Hospitals
To understand the trust gap, it helps to first understand the genuine, verified contributions AI is already making in American healthcare.
In radiology, AI has emerged as a legitimate clinical partner. A landmark study tracking over 100,000 CT scans and nearly 400 radiologists during the rollout of a real-world FDA-approved diagnostic platform found that when AI flags pulmonary embolism, radiologists agree 84% of the time; when AI predicts no PE, they agree 97%. Despite a 16% increase in scan volume, diagnostic speed remains stable while per-radiologist monthly volumes nearly double, with no change in patient mortality — suggesting AI improves workflow without compromising outcomes.
In clinical documentation, as reported in Article 3, ambient AI scribes are cutting burnout, saving thousands of physician hours, and improving note quality. In drug discovery, AI is compressing years of research into months. In genomic analysis, in patient triage, in hospital operations — AI is producing measurable, verifiable results at a scale that was not possible five years ago.
With 1,000-plus AI-powered tools already FDA-cleared, the discussion is shifting from AI's potential to its measurable impact on efficiency, care coordination, and patient experience, according to Julia Strandberg, Chief Business Leader, Connected Care at Philips.
Where the Trust Problem Lives — and Why It Matters
The trust problem in AI healthcare is not primarily about whether AI tools work. Many of them work remarkably well. The problem is about governance: who verifies that a specific AI tool is accurate in a specific clinical context? Who is responsible when it is wrong? How is that information communicated to clinicians and patients?
In many hospitals today, the answers to those questions are unclear. AI tools vary enormously in their quality, clinical validation, and transparency about their limitations. A physician using an AI-assisted diagnostic tool may not know whether it was trained on a dataset that reflects their patient population, whether it has been validated in the specific clinical scenario they are facing, or what its error rate is for patients of a given age, race, or comorbidity profile.
Health systems are expected to play catch-up with governance, building out more formal compliance policies to address the risks of shadow AI — a term used for AI tools that clinicians adopt informally, outside institutional oversight channels. Shadow AI in healthcare is a real and growing concern: when doctors and nurses begin using consumer AI tools (including general-purpose chatbots) to inform clinical decisions without institutional vetting, the potential for harm is significant.
For patients, the parallel concern is equally serious. This always-on access to medical information is creating a new dynamic between patients and their care providers — one in which patients may arrive with AI-generated self-diagnoses that conflict with clinical reality, or decline recommended treatments based on AI outputs they cannot fully evaluate.
What Patients Should Know Before Their Next Appointment
For American healthcare consumers, the practical takeaway from the 2026 Future Health Index is this: AI is already part of your care, whether you have been told so explicitly or not. Understanding that fact — and asking questions about it — is a reasonable and appropriate step.
Patients are within their rights to ask their physician or hospital whether AI tools are being used in their care, what those tools do, and how the results are reviewed by a human clinician before affecting their treatment. The answer should always be that a qualified physician or advanced practice provider reviews and takes responsibility for any AI-assisted output.
At the same time, patients who use AI tools to research their own health should do so with genuine critical awareness. Consumer AI tools — including general-purpose chatbots — are not trained as clinical decision-support systems, are not regulated by the FDA, and should not be used as a substitute for professional medical evaluation. They can be useful for understanding terminology, preparing questions for an appointment, or learning about a newly diagnosed condition. They should not be used to self-diagnose, self-treat, or override a physician's recommendation.
"Time savings translate into more than operational efficiencies," said Carla Goulart Peron, Chief Medical Officer at Philips. "Half of the clinicians we surveyed report experiencing less stress and a better work-life balance. Patients experience these benefits directly through higher-quality interactions, the attention they receive during appointments, and the time clinicians have to listen."
The challenge ahead is not whether AI belongs in medicine. The evidence is overwhelming that it does. The challenge is ensuring that the speed of adoption does not outrun the quality of governance — and that the patients who depend on U.S. healthcare can trust not just that AI is being used, but that it is being used wisely, safely, and in their interest.
Frequently Asked Questions
Is AI already being used in my doctor's office? Almost certainly in some form. AI tools are used in radiology interpretation, electronic health record documentation, clinical decision support, appointment scheduling, and more in the vast majority of U.S. hospital systems as of 2026.
Should I trust AI for medical advice? Consumer AI tools can help you understand medical information and prepare questions for your doctor, but they are not substitutes for professional clinical evaluation and should not be used to self-diagnose or override physician recommendations.
What is "shadow AI" in healthcare? Shadow AI refers to AI tools — including general-purpose consumer chatbots — used by clinicians or hospital staff outside official institutional oversight. This is a recognized safety concern because unvetted AI tools may produce errors that go undetected without proper governance.
What should I ask my doctor about AI? Ask whether AI tools are being used in your care, what they are being used for, and how a human clinician reviews their outputs before they affect your treatment. These are reasonable, appropriate questions that any healthcare provider should be able to answer.
How is the FDA regulating AI in medicine? The FDA has cleared more than 1,000 AI-powered medical devices as of 2026, primarily in imaging and diagnostics. Regulation of AI in clinical decision support and documentation is still evolving, and governance gaps remain an active area of policy discussion.
